Literature DB >> 1579760

A semi-Bayes approach to the analysis of correlated multiple associations, with an application to an occupational cancer-mortality study.

S Greenland1.   

Abstract

Thomas et al. presented the application of empirical-Bayes methods to the problem of multiple inference in epidemiologic studies. One limitation of their approach, which they noted, was the need to assume exchangeable log relative-risk parameters, and independent relative-risk estimates. Numerical integration was also required. Here I generalize their approach to allow for non-exchangeable parameters and non-independent estimates. The resulting method is Bayesian in so far as some feature of the prior distribution are specified from prior information, but is empirical Bayes in so far as some explicit parameters in the prior distribution are estimated from the data. Estimation is based on approximations to the posterior distribution; this allows one to implement the approach with standard software packages for matrix algebra. The method is illustrated in an occupational mortality study of 84 exposure-cancer associations.

Entities:  

Mesh:

Year:  1992        PMID: 1579760     DOI: 10.1002/sim.4780110208

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  27 in total

1.  Association of Parkinson's disease with industry sectors: a French nationwide incidence study.

Authors:  Tim Vlaar; Sofiane Kab; Yannick Schwaab; Nadine Fréry; Alexis Elbaz; Frédéric Moisan
Journal:  Eur J Epidemiol       Date:  2018-05-05       Impact factor: 8.082

2.  Dose-response relations between occupational exposures to physical and psychosocial factors and the risk of low back pain.

Authors:  J P Jansen; H Morgenstern; A Burdorf
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

3.  Enriching the analysis of genomewide association studies with hierarchical modeling.

Authors:  Gary K Chen; John S Witte
Journal:  Am J Hum Genet       Date:  2007-06-26       Impact factor: 11.025

4.  The use of hierarchical models for estimating relative risks of individual genetic variants: an application to a study of melanoma.

Authors:  Marinela Capanu; Irene Orlow; Marianne Berwick; Amanda J Hummer; Duncan C Thomas; Colin B Begg
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

5.  Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.

Authors:  Travis J Meyers; Shen-Chih Chang; Po-Yin Chang; Hal Morgenstern; Donald P Tashkin; Jian-Yu Rao; Wendy Cozen; Thomas M Mack; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2017-02-22       Impact factor: 7.396

6.  Nonparametric bayes shrinkage for assessing exposures to mixtures subject to limits of detection.

Authors:  Amy H Herring
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

7.  Multiple human papillomavirus infections and type competition in men.

Authors:  Anne F Rositch; Charles Poole; Michael G Hudgens; Kawango Agot; Edith Nyagaya; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2011-11-04       Impact factor: 5.226

8.  Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events.

Authors:  Meijia Zhou; Charles E Leonard; Colleen M Brensinger; Warren B Bilker; Stephen E Kimmel; Todd E H Hecht; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2020-05-16       Impact factor: 6.875

9.  Nutrient pathways and breast cancer risk: the Long Island Breast Cancer Study Project.

Authors:  Patrick T Bradshaw; Nikhil K Khankari; Susan L Teitelbaum; Xinran Xu; Brian N Fink; Susan E Steck; Mia M Gaudet; Geoffrey C Kabat; Mary S Wolff; Alfred I Neugut; Jia Chen; Marilie D Gammon
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

10.  Bayesian mixture modeling of gene-environment and gene-gene interactions.

Authors:  Jon Wakefield; Frank De Vocht; Rayjean J Hung
Journal:  Genet Epidemiol       Date:  2010-01       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.